Literature DB >> 17393105

Effects of exogenous p16(ink4a) gene on biological behaviors of human lung cancer cells.

Xiaoju Zhang1, Yang Jin, Xiaonan Tao, Ming Bai.   

Abstract

The effects of exogenous p16(ink4a) gene on biological behaviors of human lung cancer cell line with homozygous deletion of p16(ink4a) gene were investigated. Exogenous p16(ink4a) gene was transfected by lipofectin into human lung cell line A549, in which p16(ink4a) gene was homozygously deleted. The expression of p16(ink4a) mRNA and protein was detected by RT-PCR and immunocyto-chemistry, respectively. The changes in the behaviors of the transfected cell lines in vitro and in vivo were observed. In the transfected cell line A549, the exogenous p16(ink4a) gene could be stably expressed. The growth of A549 cells transfected with p16(ink4a) gene was obviously slowed down. Flow cytometry revealed that transfection of the exogenous p16(ink4a) gene resulted in A549 cell lines arrest in G1 phase of cell cycle. The tumorigenicity of these transfected cells in nude mice could be inhibited, and the tumor growth of nude mice was significantly suppressed. It was concluded that exogenous p16(ink4a) gene may be stably expressed in human lung cancer cell line A549. The expression of the introduced p16(ink4a) could block lung cancer cells to entry into S phase of cell cycle and inhibit tumor malignant growth both in vitro and in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17393105     DOI: 10.1007/s11596-007-0111-4

Source DB:  PubMed          Journal:  J Huazhong Univ Sci Technolog Med Sci        ISSN: 1672-0733


  9 in total

1.  P16INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation.

Authors:  S Kobayashi; H Shirasawa; H Sashiyama; H Kawahira; K Kaneko; T Asano; T Ochiai
Journal:  Clin Cancer Res       Date:  1999-12       Impact factor: 12.531

2.  p16(INK4A) Hypermethylation detected by fluorescent methylation-specific PCR in plasmas from non-small cell lung cancer.

Authors:  Alessandra Bearzatto; Davide Conte; Milo Frattini; Nadia Zaffaroni; Francesca Andriani; Debora Balestra; Luca Tavecchio; Maria Grazia Daidone; Gabriella Sozzi
Journal:  Clin Cancer Res       Date:  2002-12       Impact factor: 12.531

3.  Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus.

Authors:  J K Wolf; T E Kim; D Fightmaster; D Bodurka; D M Gershenson; G Mills; J T Wharton
Journal:  Gynecol Oncol       Date:  1999-04       Impact factor: 5.482

4.  Aberrant promoter methylation of multiple genes in non-small cell lung cancers.

Authors:  S Zöchbauer-Müller; K M Fong; A K Virmani; J Geradts; A F Gazdar; J D Minna
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

5.  Evidence for three tumor suppressor loci on chromosome 9p involved in melanoma development.

Authors:  P M Pollock; J Welch; N K Hayward
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

6.  Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.

Authors:  P M Thompson; J M Maris; M D Hogarty; R C Seeger; C P Reynolds; G M Brodeur; P S White
Journal:  Cancer Res       Date:  2001-01-15       Impact factor: 12.701

Review 7.  Molecular abnormalities in lung cancer.

Authors:  R Salgia; A T Skarin
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

Review 8.  Role of the p16 tumor suppressor gene in cancer.

Authors:  W H Liggett; D Sidransky
Journal:  J Clin Oncol       Date:  1998-03       Impact factor: 44.544

9.  Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines.

Authors:  G I Shapiro; J E Park; C D Edwards; L Mao; A Merlo; D Sidransky; M E Ewen; B J Rollins
Journal:  Cancer Res       Date:  1995-12-15       Impact factor: 12.701

  9 in total
  2 in total

1.  Comparison of the inhibitory effects of three transcriptional variants of CDKN2A in human lung cancer cell line A549.

Authors:  Wei Zhang; Jing Zhu; Jing Bai; Hui Jiang; Fangli Liu; An Liu; Peng Liu; Guohua Ji; Rongwei Guan; Donglin Sun; Wei Ji; Yang Yu; Yan Jin; Xiangning Meng; Songbin Fu
Journal:  J Exp Clin Cancer Res       Date:  2010-06-17

Review 2.  Evaluation of the use of therapeutic peptides for cancer treatment.

Authors:  Susan Marqus; Elena Pirogova; Terrence J Piva
Journal:  J Biomed Sci       Date:  2017-03-21       Impact factor: 8.410

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.